CRP and COVID-19: suPAR concentrations rise earlier in disease progression than other biomarkers -CRP, IL-6, ferritin and DD- and are indicative of dangerous associated molecular patterns (DAMPs) such as calprotectin (S100A8/A9) and IL-1α which contribute to pathogenic inflammation in COVID-19.